Friday, January 20, 2017

Today’s articles on Sectors

A Big Day For AT&T
By Christopher F. Davis • 23 comments
Berkshire Hathaway Is Not Built To Last
By Timberwolf Equity Research • 136 comments
New Deal Talk As Tesla Hits Ludicrous Speed
By Chris DeMuth Jr. • 33 comments
Editors' Picks
Double-Digit Market Decline Possible In Near Future (Chris DeMuth)
By Brian Bain
Berkshire Hathaway: Potential For $95 Billion In Book Value Growth By Year-End 2017
By Left Shark Investing
Exxon Mobil: A Transaction The Market Has Been Waiting For
By Richard Zeits
Exxon Mobil: Permian Acquisition, Strategy And Oil Pricing
By Jennifer Warren
Colony NorthStar Delivered A 50% Return - What's Next?
By John Sheehy
More Editors' Picks»

Basic Materials
Kinder Morgan - Cash Flow King by The Value Portfolio
2 Gold Producers Ripe For Takeovers by Taylor Dart
Market Challenge: What's Next For Kinder Morgan Investors? by SA Editor Michael Hopkins
Royal Dutch Shell: A Lot Of Debt by Brandon Dempster
Lithium Americas Is Looking Good And Is Now Significantly De-Risked by Matt Bohlsen
More Basic Materials»
Conglomerates
Zodiac Aerospace (ZODFF) Announces Acquisition By Safran (SAFRY) by SA Transcripts
More Conglomerates»

Consumer Goods
Another Dividend Champion About To Sell At A Discount by Black Coral Research
Tesla: Do You Believe Morgan Stanley? by Paulo Santos
Coca-Cola: A Few Overlooked Facts About This Dividend Aristocrat by Integer Investments
Ford's Electric Vehicle Strategy Sliced And Diced by Brian Morin
How Jaguar Outgrew Tesla In 2016 by Anton Wahlman
More Consumer Goods»
Financial
The MATRIX: Trump, Paul Krugman And U.S. Bank Valuations by FIG Ideas
New Residential's Performance Is Loved, And It Might Get Better by David White
Update: Realty Income's 4% Dividend Increase And Its Validation Of Holding Without Selling For Capital Gains by Harry Polizzi
Citi Crushes It In Q4 by Josh Arnold
Citigroup: What A Disappointment by Shock Exchange
More Financial»
Healthcare
Cure Your Portfolio With Gilead by Blue Chip Investing
Gilead: I'm Sorry (But It's Even Better Than I Thought) by From Growth to Value
What To Make Of Synergy Pharmaceuticals With Key PDUFA Date Approaching by Bret Jensen
How Will Gilead Fare In 2017? by Jonathan Weber
AbbVie And ANI Pharmaceuticals Appear Poised To Announce A Deal For LibiGel by Just the Facts Maam
More Healthcare»
Industrial Goods
Boeing's 737-10X by Air Insight
Einhorn: Short Caterpillar Under Trump by David Pinsen
Asymmetric Allocation: 3 Reasons Why SRCL/SMED Is A Great Long/Short Reversion To The Mean Story by Nelson Nguyen, CFA
Novozymes A/S ADR 2016 Q4 - Results - Earnings Call Slides by SA Transcripts
More Industrial Goods»
Services
DryShips: Here We Go Again by Bill Maurer
DryShips: The Party Continues by Christopher F. Davis
CSX: About That Jump by Jonathan Weber
Target: In Deep Trouble by Hedgeye
Is Now The Time To Buy Visa? by Benjamin Black
More Services»
Technology
AMD's Financials Still Drowning Bullish Fundamentals by Individual Trader
International Business Machines' (IBM) Management on Q4 2016 Results - Earnings Call Transcript by SA Transcripts
IBM: Where Did My Yields Go? by Stone Fox Capital
M&A Speculation, Trump And What It All Means For Cisco's Future by Black Coral Research
Qualcomm Will Not Cower by Nikhil Gupta
More Technology»
Utilities
Algonquin Power: Still Time To Buy This Mid-Cap Utility by George Fisher
Avista Corporation, It's Not Just Water Over The Dam by PendragonY
NiSource: 4-6% Annual Growth Backed By $30bn Capex Over 20-30 Years by Jefferson Ridge
A Utility Set To Benefit From Increasing Environmental Regulations And Legalized Marijuana by Matthew Utesch
More Utilities»

Please do not forward this email. It allows direct access to your Seeking Alpha Portfolio.

Why are you receiving this? You subscribed to Sectors at Seeking Alpha.
Unsubscribe from this email or manage all your Seeking Alpha email choices here.
To ensure you receive these emails in the future, please add account@seekingalpha.com to your address book, contacts or list of safe senders.
Sent by Seeking Alpha, 52 Vanderbilt Avenue, 13th floor, New York, NY 10017

No comments:

Post a Comment

Gimme your 2 cents!

Banner Ad